About Clevergene
Clevergene is a Healthcare company based in Bengaluru (India) founded in 2013 by Tony Jose. Genomic-based bioinformatics solutions are provided for research and translational sciences. Clevergene has raised $632.77 thousand across 1 funding round from investors including Auxano and Ajay Kuamr. The company has 2 employees. Clevergene was last valued at $4.05 million in January 2020. Its chief executive, as recorded, is Tony Jose. Its Indian entity Clevergene Biocorp Private Limited reported revenue of ₹9.97 Cr. Clevergene offers products and services including Genome Sequencing, Epigenome Sequencing, Metagenome Sequencing, RNA Sequencing, and Single Cell Expression. Its focus areas include Life Sciences, Genomics, Genomics Services and Sequencing.
Company details
Clevergene was founded in 2013 in Bengaluru, India, focusing on the bioinformatics sector. Genomic-based solutions are delivered for research and translational sciences through high-throughput DNA sequencing and big data analytics. Problems in these areas are addressed via services such as genome analysis, transcriptome analysis, SNP analysis, epigenome analysis, small RNA analysis, statistical modeling, metagenome analysis, CNV analysis, and microarray data analysis. Operations center on analytics and sequencing technologies.
- Headquarters Bengaluru, India
- Employees 2
- Founders Tony Jose
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website clevergene.in
- Social LinkedIn X Facebook Instagram
- Legal Name Clevergene Biocorp Private Limited
- Date of Incorporation 04 Jun, 2013
- Jurisdiction Bengaluru, Karnataka, India
- Annual Revenue₹9.97 Cr
FY 2022 · +39% YoY
- Net Loss-₹1.74 Cr
FY 2022 · -17% margin
- EBITDA₹1.14 Cr
FY 2022 · 11% margin
- Total Equity Funding$632.77K (USD)
in 1 rounds
- Latest Funding Round$632.77K (USD), Seed
Jan 2020
- InvestorsAuxano
& 1 more
- Employee Count2
Associated legal entities of Clevergene
Clevergene operates through Clevergene Biocorp Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Clevergene Biocorp Private Limited CIN U73200KA2013PTC069488 | Active | 04 Jun 2013 | Bengaluru, Karnataka | ₹10.0 Cr | 2 | 3 | View details |
Products & Services of Clevergene
Clevergene offers a comprehensive portfolio of products and services, including Genome Sequencing, Epigenome Sequencing, Metagenome Sequencing, RNA Sequencing, and Single Cell Expression.
Service for assembling genomes and identifying genetic variants.
Analyzes epigenetic changes in biological samples.
Profiles microbial communities through genomic analysis.
Measures gene expression in various biological contexts.
Examines gene expression at the single-cell level.
Offers solutions for genetic ailment diagnostics.
Funding Insights of Clevergene
Clevergene has successfully raised a total of $632.77K through 1 strategic funding round. The most recent funding activity was a Seed round of $632.77 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $632,769
- Total Rounds 1
- Last Round Seed — $632,769
- First Round $632,769
(Jan 2020)
- Investors Count 2
All 1 funding rounds of Clevergene with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2020 | $632,769 | Seed | $4.05M | Auxano Capital |
| Date | Valuation | Stage |
|---|---|---|
| Jan 2020 | $4.05M | •••••••• |
Last known valuation $4.05M (Jan 2020). 2 investors in total: 1 institutional and 1 angel.
Investors in Clevergene
Clevergene has secured backing from 2 investors, including venture fund and angel investors. Prominent investors backing the company include Auxano and Ajay Kuamr.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment funding and strategic guidance are provided by Auxano. | auxano.in | Gurugram, India | ||
AK Ajay Kuamr | Angel investor, ex-entrepreneur, focused on Indian startups in tech and consumer sectors. | unknown_080d6b5a82ce46ef9 |
Investor details for Clevergene
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Clevergene Biocorp Private Limited (Clevergene)
Clevergene Biocorp Private Limited is the primary company behind Clevergene. The board of Clevergene Biocorp Private Limited currently have 3 directors; the longest-serving is Tony Jose, appointed in 2013. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tony Jose DIN 06535236 | Director | 04 Jun 2013 | 13 yrs 5 mo | Clevergene Biocorp Private Limited |
| Antony Thomas DIN 07519261 | Director | 16 May 2016 | 10 yrs 5 mo | Clevergene Biocorp Private Limited |
| Ria Dutta DIN 11212032 | Director | 10 Nov 2025 | 11 mo | Clevergene Biocorp Private Limited |
People of Clevergene
1 people are tracked at Clevergene (1 in leadership); the tracked headcount is 2.
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership |
Complete people profiles for Clevergene
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Clevergene
Figures of Clevergene Biocorp Private Limited, the primary company behind Clevergene, for FY 2022. Revenue was ₹9.97 Cr (+39% year on year). Net loss was -₹1.74 Cr (-17% margin). EBITDA was ₹1.14 Cr (11% margin). Revenue has grown at a compounded annual rate of +60% over three years and +108% over five years.
- ₹9.97 CrRevenue · FY 2022 · +39% YoY
- -₹1.74 CrNet loss · -17% margin
- ₹1.14 CrEBITDA · 11% margin
- ₹2.7 LakhPaid-up capital
- 2Employees (provident fund records)
- +60%Revenue CAGR, 3 years
- +108%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Clevergene Biocorp Private Limited are on its company page.
Detailed financial statements for Clevergene
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Clevergene
3 dated milestones of Clevergene across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Clevergene is founded.
- Funding First funding round of $633K.
- Milestone Reaches Minicorn status.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Clevergene
Complete news archive for Clevergene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clevergene
Clevergene was founded in 2013 and raised its 1st funding round 7 years after it was founded.
Clevergene is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Tony Jose is the CEO of Clevergene, as recorded in our data. They have also founded this company.
Clevergene is a funded company, having raised a total of $632.77K across 1 funding round to date. The company's 1st funding round was a Seed of $632.77K, raised on Jan 2020.
Clevergene has 2 employees.
The primary company behind Clevergene, Clevergene Biocorp Private Limited, reported revenue of ₹9.97 Cr for FY 2022, up 39% year on year.
Clevergene was founded in 2013 in Bengaluru, India, focusing on the bioinformatics sector. Genomic-based solutions are delivered for research and translational sciences through high-throughput DNA sequencing and big data analytics. Problems in these areas are addressed via services such as genome analysis, transcriptome analysis, SNP analysis, epigenome analysis, small RNA analysis, statistical modeling, metagenome analysis, CNV analysis, and microarray data analysis. Operations center on analytics and sequencing technologies.
Clevergene offers Genome Sequencing, Epigenome Sequencing, Metagenome Sequencing, RNA Sequencing, and 2 more products and services.
Clevergene has 2 investors. Key investors include Auxano, and Ajay Kuamr.
The valuation of Clevergene is $4.05M as of Jan 2020.
Clevergene operates through Clevergene Biocorp Private Limited.
The legal entities of Clevergene currently have 3 directors, including Antony Thomas, Tony Jose, Ria Dutta.